About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does VILYA do?
Vilya pioneers computational drug design, creating entirely new de novo macrocycles inspired by biology and designed using AI. Their platform generates, predicts, and validates these molecules in silico, aiming to develop orally bioavailable therapies that combine the selectivity of biologics with the convenience of pills. Vilya serves the pharmaceutical and biotechnology industries by advancing a new class of medicines for previously untreatable diseases.
How much funding has VILYA raised?
VILYA has raised a total of $131M in funding. The most recent round on record is Series A.
Where is VILYA headquartered?
VILYA is headquartered in San Francisco, United States.
When was VILYA founded?
VILYA was founded in 2022.
What industry does VILYA operate in?
VILYA operates in BIO + LIFE SCIENCES, Biotech, Drug Discovery, Genomics, AI-Driven Protein Design, HealthTech.
How many employees does VILYA have?
VILYA has approximately 47 people on record.